Tirzepatide

Description

Tagline / One-Liner

Dual-action. Single focus: advancing metabolic research.

High-Level Summary

Tirzepatide is a novel dual agonist of the GLP-1 and GIP receptors, engineered to provide a synergistic approach to metabolic regulation. This next-generation incretin mimetic is at the forefront of research in obesity, insulin resistance, and type 2 diabetes. By targeting both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, Tirzepatide enhances insulin secretion, suppresses glucagon, and modulates appetite and gastric motility.

– Form: Lyophilized peptide
– Purity: ≥99%
– Origin: Manufactured and tested in the USA
– Certifications: Certificate of Analysis (COA) included with every order

Mechanism of Action (MOA)

Tirzepatide is a synthetic peptide designed to activate both GLP-1 and GIP receptors. Upon binding:
– Stimulates insulin secretion in a glucose-dependent manner
– Suppresses glucagon during hyperglycemia
– Delays gastric emptying to promote satiety
– Enhances adipocyte insulin sensitivity
– Reduces appetite via central nervous system pathways

Research Applications

– Dual incretin pathway investigation
– Obesity and type 2 diabetes models
– Appetite and food intake modulation
– Insulin and glucagon dynamics
– Cardiometabolic risk factor studies

Key Benefits for Research

– Dual receptor targeting provides enhanced efficacy
– Long-acting formulation mimics clinical pharmacokinetics
– Validated in preclinical and translational models
– High purity for consistent and reproducible outcomes

Certificate of Purity & Testing

Each vial is:
– Manufactured in a GMP-compliant U.S. facility
– Accompanied by a Certificate of Analysis (COA)
– Subjected to HPLC and mass spectrometry verification
– Shipped from within the United States for quality control

Formulation & Dosage Info

– Contents: 5mg of lyophilized Tirzepatide peptide
– Appearance: White/off-white powder
– Solubility: Sterile bacteriostatic water or acetic acid recommended
– Storage: Store lyophilized vial at -20°C; reconstituted solution stable up to 30 days when refrigerated
*For laboratory research use only. Not intended for human or veterinary use.*

Legal & Compliance Notices

– This product is sold for research purposes only
– Not for human consumption, injection, or diagnostic procedures
– Must be handled by qualified professionals in accordance with institutional and governmental safety guidelines